Study title:
Hatchette T, Tipples GA, Peters G, Alsuwaidi A, Zhou J, Mailman TL. Foscarnet salvage therapy for
acyclovir-resistant varicella zoster:
report of a novel thymidine kinase
mutation and review of the
literature. Pediatr Infect Dis J.
2008 Jan;27(1):75-7.Hatchette T, Tipples GA, Peters G, Alsuwaidi A, Zhou J, Mailman TL. Foscarnet salvage therapy for
acyclovir-resistant varicella zoster:
report of a novel thymidine kinase
mutation and review of the
literature. Pediatr Infect Dis J.
2008 Jan;27(1):75-7.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Virus Diseases [C02]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: Foscarnet |
ATC code: |
Document link:
Hatchette T et al 2008.pdf
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|